Xbrane Biopharma AB
Kiavash Mirzadeh is a Senior Scientist at Xbrane Biopharma AB since January 2019 and has also been a Co-founder and Vice CEO of CloneOpt since 2015. Previously, Kiavash served as a Postdoctoral Researcher in the Department of Biochemistry and Biophysics at Stockholms universitet from September to December 2018. Kiavash holds a Doctor of Philosophy (PhD) in Biochemistry from Stockholm University, earned between 2013 and 2018, and obtained a Master's degree in Biochemistry from the same institution from 2010 to 2013. Additionally, Kiavash attended KTH Royal Institute of Technology in 2009-2010.
This person is not in any teams
Xbrane Biopharma AB
Xbrane is a biopharmaceutical company specialized in high demand complex generics.The segment have a high entry barrier, driven by high production complexity and the need of specific Know-How. Xbrane currently possess it own expertise within production of complex generics with slow release formulation and unique technologies for producing Proteinsefficiently.